Poster PEDS - Heart Transplantation

997 - Evaluation of Prophylactic Valganciclovir for Cytomegalovirus (CMV) in Pediatric Heart Transplant Recipients

Presentation Number
997
Presenter
Session Name
PO-2-PEDS - Poster Session 2: Pediatric Transplantation
Date
Thu, Apr 12, 2018
Time
06:15 PM - 07:15 PM
Co-Authors

Previous Eposter
1127 - The Impact of Gender Mismatch on Survival After Heart Transplantation

Next Eposters
1423 - Negative Pressure Wound Therapy Prevents Infection and Allows for Rehabilitation in a Child on Long-Term Mechanical Circulatory Support
1162 - Role of dd-cfDNA in Predicting Early Post-operative Course in Lung Transplant Recipients
1163 - Predicting Risk of Early Readmission in Lung Transplant Recipients Using dd-cfDNA
590 - Outcomes of Lung Transplantation in Septuagenarian Recipients
819 - Ischemic but Not Dilative Cardiomyopathy Impairs the Thioredoxinsystem in the Myocardium
717 - Usefulness of Near-infrared Reflectance Spectroscopy to Assess Lower-limb Perfusion on Femoral Veno-arterial Extracorporeal Membrane Oxygenation
582 - Acceptable Peri-Operative Risk for Cardiac Transplant: Physician and Patient Perspectives
1172 - Diagnostic Value of Peripheral and Bronchoalveolar Leukocyte Profile in Lung Transplant Recipients After Alemtuzumab Induction Therapy. A Single Center Experience
1421 - When Two Cardiomyopathies Are Better Than One: Novel Genetic Mutation With LVNC and Unilateral Restrictive Features in a Child
731 - Long-Term Follow up and Predicting Factors of de Novo Aortic Regurgitation after LVAD Implantation